BRITISH AMERICAN TOBACCO ZIMBABWE HOLDINGS LIMITED (BAT)
Zimbabwe Stock Exchange · Zimbabwe · prices in ZWL · close of 22 Oct 2026
Key indicators
| Last close | ZWL 19,000.00 |
|---|---|
| 52-week range | 7,000.00 – 24,711.00 |
| Return, 1 month / 3 months | +29.7% / +0.1% |
| Return, 1 year / 3 years | +65.2% / −98.1% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 88.0% |
| Worst drawdown (1 year) | -41.3% |
| Average daily value traded | 8.73M ZWL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
British American Tobacco Zimbabwe Holdings makes and sells cigarettes and other tobacco products in Zimbabwe. The company runs a cigarette factory in Harare and supplies its brands to wholesalers, retailers and distributors across the country. It also buys tobacco leaf from local farmers for use in its manufacturing. The business is the Zimbabwean arm of a global tobacco group and serves adult smokers in the local market through a network of trade customers.
BRITISH AMERICAN TOBACCO ZIMBABWE HOLDINGS LIMITED trades under the code BAT on the Zimbabwe Stock Exchange in Zimbabwe, with its price quoted in Zimbabwe dollars (ZWL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BRITISH AMERICAN TOBACCO ZIMBABWE HOLDINGS LIMITED (BAT) trades on the Zimbabwe Stock Exchange in Zimbabwe. It last closed at ZWL 19,000.00 on 22 October 2026.
Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 35 of 40 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 65.2% and over the last three months it rose 0.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Zimbabwe Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 27 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 3.8% | ||
| From 52-week high | -23.1% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.1% | ||
| 6-month return | -0.9% | ||
| 12-month return, skipping the last month | 27.4% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 88.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.3% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 8.73M ZWL | ||
| Zero-volume days | 65.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +29.7% |
| 3 months | +0.1% |
| 6 months | −0.9% |
| 1 year | +65.2% |
| 3 years | −98.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 17,633.22 / 18,298.41 |
|---|---|
| Golden / death cross (60 days) | Death, 13 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 228.11 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Zimbabwe Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.